Medical Market Report

Global Antidiabetic Drug Market By Type (Alpha-Glucosidase Inhibitors, Biguanides, Sulphonylureas, Glp-1 Agonist, Meglitinides, Dpp-4 Inhibitors, Sglt?2, and Thiazolodinediones), By Application (Type I Diabetes, and Type II Diabetes), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

  • 133899
  • 12-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    The report on Antidiabetic Drug Market offers in-depth analysis on market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report include the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The global antidiabetic drug market is segmented on the basis of Type, Application and geography.

    The worldwide market for Antidiabetic Drug Market is expected to grow at a CAGR of roughly x.x% over the next ten years and will reach US$ XX.X Mn in 2028, from US$ XX.X Mn in 2018, according to a new Market.us (Prudour Research) study.

    Antidiabetic Drug Market Scope:

    By type, the market is segmented into Alpha-Glucosidase Inhibitors, Biguanides, Sulphonylureas, Glp-1 Agonist, Meglitinides, Dpp-4 Inhibitors, Sglt?2 and Thiazolodinediones. By Application, the market is divided into I Diabetes, and II Diabetes. Based on geography, market is analyzed across North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. Major players profiled in the report include Sanofi-Aventis, Eli Lilly, Oramed, Takeda, Boehringer Ingelheim, Novo Nordisk, Halozyme Therapeutics, Bristol-Myers Squibb, Pfizer, Tonghua Dongbao, Biocon and Wockhardt.

    Key Market Segments

    Type

    Alpha-Glucosidase Inhibitors
    Biguanides, Sulphonylureas
    Glp-1 Agonist
    Meglitinides
    Dpp-4 Inhibitors
    Sglt?2
    Thiazolodinediones

    Application

    I Diabetes

    II Diabetes

    Key Market Players included in the report:

    Sanofi-Aventis
    Eli Lilly
    Oramed
    Takeda
    Boehringer Ingelheim
    Novo Nordisk
    Halozyme Therapeutics
    Bristol-Myers Squibb
    Pfizer
    Tonghua Dongbao
    Biocon
    Wockhardt

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Antidiabetic Drug Market share analysis of high players, along with company profiles and which collectively include about the fundamental opinions regarding the market landscape. Emerging and high-growth sections of Antidiabetic Drug Market, high-growth regions, and market drivers, restraints and also market chances.
    The analysis covers Antidiabetic Drug Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Antidiabetic Drug Market across sections such as also Application and representatives.
    Additionally, the analysis also has a comprehensive review of the crucial players on the Antidiabetic Drug Market together side their company profiles, SWOT analysis, latest advancements and business plans.

    The analysis objectives of the report are:

    ?

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers and industry-specific challenges and risks).
    To know the Antidiabetic Drug Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of Antidiabetic Drug sub-markets, depending on key regions (various vital states).
    To analyze Antidiabetic Drug Market concerning growth trends, prospects and also their participation in the entire sector.
    To examine and study the Antidiabetic Drug Market size (volume & value) from the company, essential regions/countries, products and Application, background information from 2012 to 2018 and also prediction to 2028.
    Primary worldwide Antidiabetic Drug Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches and acquisitions on the market.

    ?

  • Table Of Content 
    1. Antidiabetic Drug Market Introduction
    

    1.1. Definition
    
1.2. Taxonomy
    
1.3. Research Scope2. Executive Summary
    

    2.1. Key Findings by Major Segments
    
2.2. Top strategies by Major Players3. Global Antidiabetic Drug Market Overview
    

    3.1. Antidiabetic Drug Market Dynamics
    

    3.1.1. Drivers
    
3.1.2. Opportunities
    
3.1.3. Restraints
    
3.1.4. Challenges3.2. PESTLE Analysis
    
3.3. Opportunity Map Analysis
    
3.4. PORTER’S Five Forces Analysis
    
3.5. Market Competition Scenario Analysis
    
3.6. Product Life Cycle Analysis
    
3.7. Opportunity Orbits
    
3.8. Manufacturer Intensity Map4. Global Antidiabetic Drug Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
    

    4.1. Global Antidiabetic Drug Market Analysis by Type: Introduction
    
4.2. Market Size and Forecast by Region
    
4.3. Alpha-Glucosidase Inhibitors
    
4.4. Biguanides, Sulphonylureas
    
4.5. Glp-1 Agonist
    
4.6. Meglitinides
    
4.7. Dpp-4 Inhibitors
    
4.8. Sglt?2
    
4.9. Thiazolodinediones5. Global Antidiabetic Drug Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
    

    5.1. Global Antidiabetic Drug Market Analysis by Application: Introduction
    
5.2. Market Size and Forecast by Region
    
5.3. Type I Diabetes
    
5.4. Type II Diabetes6. Global Antidiabetic Drug Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
    

    6.1. North America
    

    6.1.1. North America Antidiabetic Drug Market: Regional Trend Analysis
    

    6.1.1.1. US
    
6.1.1.2. Canada
    
6.1.1.3. Mexico
    

    6.2. Europe
    

    6.2.1. Europe Antidiabetic Drug Market: Regional Trend Analysis
    

    6.2.1.1. Germany
    
6.2.1.2. France
    
6.2.1.3. UK
    
6.2.1.4. Russia
    
6.2.1.5. Italy
    
6.2.1.6. Rest of Europe
    

    6.3. Asia-Pacific
    

    6.3.1. Asia-Pacific Antidiabetic Drug Market: Regional Trend Analysis
    

    6.3.1.1. China
    
6.3.1.2. Japan
    
6.3.1.3. Korea
    
6.3.1.4. India
    
6.3.1.5. Rest of Asia
    

    6.4. Latin America
    

    6.4.1. Latin America Antidiabetic Drug Market: Regional Trend Analysis
    

    6.4.1.1. Brazil
    
6.4.1.2. Argentina
    
6.4.1.3. Rest of Latin America
    

    6.5. Middle East and Africa
    

    6.5.1. Middle East and Africa Antidiabetic Drug Market: Regional Trend Analysis
    

    6.5.1.1. GCC
    
6.5.1.2. South Africa
    
6.5.1.3. Israel
    
6.5.1.4. Rest of MEA
    
7. Global Antidiabetic Drug Market Competitive Landscape, Market Share Analysis, and Company Profiles
    

    7.1. Market Share Analysis
    
7.2. Company Profiles
    
7.3. Sanofi-Aventis
    

    7.3.1. Company Overview
    
7.3.2. Financial Highlights
    
7.3.3. Product Portfolio
    
7.3.4. SWOT Analysis
    
7.3.5. Key Strategies and Developments7.4. Eli Lilly
    

    7.4.1. Company Overview
    
7.4.2. Financial Highlights
    
7.4.3. Product Portfolio
    
7.4.4. SWOT Analysis
    
7.4.5. Key Strategies and Developments7.5. Oramed
    

    7.5.1. Company Overview
    
7.5.2. Financial Highlights
    
7.5.3. Product Portfolio
    
7.5.4. SWOT Analysis
    
7.5.5. Key Strategies and Developments7.6. Takeda
    

    7.6.1. Company Overview
    
7.6.2. Financial Highlights
    
7.6.3. Product Portfolio
    
7.6.4. SWOT Analysis
    
7.6.5. Key Strategies and Developments7.7. Boehringer Ingelheim
    

    7.7.1. Company Overview
    
7.7.2. Financial Highlights
    
7.7.3. Product Portfolio
    
7.7.4. SWOT Analysis
    
7.7.5. Key Strategies and Developments7.8. Novo Nordisk
    

    7.8.1. Company Overview
    
7.8.2. Financial Highlights
    
7.8.3. Product Portfolio
    
7.8.4. SWOT Analysis
    
7.8.5. Key Strategies and Developments7.9. Halozyme Therapeutics
    

    7.9.1. Company Overview
    
7.9.2. Financial Highlights
    
7.9.3. Product Portfolio
    
7.9.4. SWOT Analysis
    
7.9.5. Key Strategies and Developments7.10. Bristol-Myers Squibb
    

    7.10.1. Company Overview
    
7.10.2. Financial Highlights
    
7.10.3. Product Portfolio
    
7.10.4. SWOT Analysis
    
7.10.5. Key Strategies and Developments7.11. Pfizer
    

    7.11.1. Company Overview
    
7.11.2. Financial Highlights
    
7.11.3. Product Portfolio
    
7.11.4. SWOT Analysis
    
7.11.5. Key Strategies and Developments7.12. Tonghua Dongbao
    

    7.12.1. Company Overview
    
7.12.2. Financial Highlights
    
7.12.3. Product Portfolio
    
7.12.4. SWOT Analysis
    
7.12.5. Key Strategies and Developments7.13. Biocon
    

    7.13.1. Company Overview
    
7.13.2. Financial Highlights
    
7.13.3. Product Portfolio
    
7.13.4. SWOT Analysis
    
7.13.5. Key Strategies and Developments7.14. Wockhardt
    

    7.14.1. Company Overview
    
7.14.2. Financial Highlights
    
7.14.3. Product Portfolio
    
7.14.4. SWOT Analysis
    
7.14.5. Key Strategies and Developments
    

    8. Assumptions and Acronyms
    
9. Research Methodology
    
10. Contact
  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.